Breaking News Instant updates and real-time market news.

NVLS

Nivalis Therapeutics

$6.25

-0.03 (-0.48%)

07:53
11/29/16
11/29
07:53
11/29/16
07:53

Nivalis Therapeutics downgraded to Neutral at Baird

As previously reported, Baird analyst Brian Skorney downgraded Nivalis Therapeutics to Neutral from Outperform following the clinical trial failure of its flagship proof-of-concept study of its drug for cystic fibrosis. Skorney lowered his price target to $3 from $29 on Nivalis Therapeutics shares. Nivalis shares have also been downgraded by at least three other firms this morning.

NVLS Nivalis Therapeutics
$6.25

-0.03 (-0.48%)

11/29/16
COWN
11/29/16
DOWNGRADE
COWN
Market Perform
Nivalis Therapeutics downgraded to Market Perform from Outperform at Cowen
11/29/16
BARD
11/29/16
DOWNGRADE
BARD
Neutral
Nivalis Therapeutics downgraded to Neutral from Outperform at Baird
11/29/16
STFL
11/29/16
DOWNGRADE
STFL
Hold
Nivalis Therapeutics downgraded on lack of drug efficacy at Stifel
As noted earlier, Stifel downgraded Nivalis to Hold from Buy. Analyst Thomas Shrader downgraded the stock after the company's cavosonstat for CF did not show meaningful efficacy in a Phase II trial. Target to $3.25 from $16.
11/29/16
COWN
11/29/16
DOWNGRADE
COWN
Market Perform
Nivalis Therapeutics downgraded to Market Perform at Cowen
As reported previously, Cowen analyst Phil Nadeau downgraded Nivalis Therapeutics to Market Perform from Outperform. The analyst said its proof-of-concept Phase 2 trial for cystic fibrosis demonstrated no benefits for lung function or sweat chloride, two established measures of activity. The drug was the company's primary asset, Nadeau noted.

TODAY'S FREE FLY STORIES

BHI

Baker Hughes

$58.65

0.97 (1.68%)

06:30
04/25/17
04/25
06:30
04/25/17
06:30
Earnings
Baker Hughes reports Q1 adjusted EPS (4c), consensus (21c) »

Reports Q1 revenue $2.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LLY

Eli Lilly

$83.42

1.53 (1.87%)

06:29
04/25/17
04/25
06:29
04/25/17
06:29
Hot Stocks
Eli Lilly backs FY17 EPS view of $4.05-$4.15, consensus $4.11 »

Backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 07

    May

  • 31

    May

WHR

Whirlpool

$174.80

3.29 (1.92%)

06:28
04/25/17
04/25
06:28
04/25/17
06:28
Hot Stocks
Whirlpool sees about $300M of raw material inflation in 2017 »

Says had sort-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

CAPR

Capricor Therapeutics

$3.09

0.08 (2.66%)

06:28
04/25/17
04/25
06:28
04/25/17
06:28
Conference/Events
Capricor Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 27

    Apr

LLY

Eli Lilly

$83.42

1.53 (1.87%)

06:27
04/25/17
04/25
06:27
04/25/17
06:27
Earnings
Eli Lilly reports Q1 EPS 98c, consensus 96c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 07

    May

  • 31

    May

WEGRY

Weir Group

$12.91

0.71 (5.82%)

06:27
04/25/17
04/25
06:27
04/25/17
06:27
Upgrade
Weir Group rating change  »

Weir Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DD

DuPont

$79.37

0.72 (0.92%)

06:26
04/25/17
04/25
06:26
04/25/17
06:26
Hot Stocks
Breaking Hot Stocks news story on DuPont »

DuPont up 2.1% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

FOX

21st Century Fox

$29.75

-0.47 (-1.56%)

, FOXA

21st Century Fox

$30.35

-0.35 (-1.14%)

06:25
04/25/17
04/25
06:25
04/25/17
06:25
Periodicals
Former presenter names Fox News executives in new lawsuit, FT says »

Andrea Tantaros, a former…

FOX

21st Century Fox

$29.75

-0.47 (-1.56%)

FOXA

21st Century Fox

$30.35

-0.35 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 15

    Jun

CTSH

Cognizant

$58.89

1.04 (1.80%)

06:24
04/25/17
04/25
06:24
04/25/17
06:24
Recommendations
Cognizant analyst commentary  »

Cognizant fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

  • 09

    May

  • 12

    May

  • 31

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

ST

Sensata

$42.76

1.71 (4.17%)

06:16
04/25/17
04/25
06:16
04/25/17
06:16
Earnings
Sensata sees FY17 adjusted EPS $3.08-$3.20, consensus $3.14 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 09

    May

PRGS

Progress Software

$29.73

0.24 (0.81%)

06:16
04/25/17
04/25
06:16
04/25/17
06:16
Hot Stocks
Progress Software appoints Dmitri Tcherevik to Chief Technology Officer »

Progress announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:15
04/25/17
04/25
06:15
04/25/17
06:15
General news
FX Action: EUR-JPY rallied to a fresh one-month peak »

FX Action: EUR-JPY…

ST

Sensata

$42.76

1.71 (4.17%)

06:13
04/25/17
04/25
06:13
04/25/17
06:13
Earnings
Sensata sees Q2 adjusted EPS 70c-80c, consensus 81c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 09

    May

GIII

G-III Apparel

$24.35

0.76 (3.22%)

, SMRT

Stein Mart

06:13
04/25/17
04/25
06:13
04/25/17
06:13
Periodicals
Stein Mart selling Ivanka Trump clothing under different label, WSJ reports »

Ivanka Trump clothing was…

GIII

G-III Apparel

$24.35

0.76 (3.22%)

SMRT

Stein Mart

JWN

Nordstrom

$47.23

-0.39 (-0.82%)

M

Macy's

$29.19

-0.29 (-0.98%)

DDS

Dillard's

$54.38

0.44 (0.82%)

TJX

TJX

$78.62

0.06 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

TECK

Teck Resources

$21.96

0.17 (0.78%)

06:13
04/25/17
04/25
06:13
04/25/17
06:13
Earnings
Teck Resources reports Q1 EPS C$1.16 vs. C$0.03 last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

PPG

PPG

$108.01

2.07 (1.95%)

, AKZO

Akzo Nobel

06:13
04/25/17
04/25
06:13
04/25/17
06:13
Periodicals
Dutch Economic Affairs Minister still opposes Akzo Nobel takeover, Reuters says »

Dutch Economic Affairs…

PPG

PPG

$108.01

2.07 (1.95%)

AKZO

Akzo Nobel

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ST

Sensata

$42.76

1.71 (4.17%)

06:12
04/25/17
04/25
06:12
04/25/17
06:12
Earnings
Sensata reports Q1 adjusted EPS 71c, consensus 68c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 09

    May

AMZN

Amazon.com

$907.41

8.88 (0.99%)

06:10
04/25/17
04/25
06:10
04/25/17
06:10
Downgrade
Raymond James downgrades Amazon with shares up 21% this year »

Raymond James analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 16

    May

  • 23

    May

PPBI

Pacific Premier

$36.75

0.7 (1.94%)

06:10
04/25/17
04/25
06:10
04/25/17
06:10
Earnings
Pacific Premier reports Q1 EPS 34c, consensus 42c »

First quarter results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

RDWR

Radware

$15.42

0.25 (1.65%)

06:10
04/25/17
04/25
06:10
04/25/17
06:10
Hot Stocks
Radware reports cash and equivalents $316M as of March 31 »

As of March 31 the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

06:10
04/25/17
04/25
06:10
04/25/17
06:10
General news
FX Action: EUR-JPY rallied to a fresh one-month peak »

FX Action: EUR-JPY…

CAPR

Capricor Therapeutics

$3.09

0.08 (2.66%)

06:09
04/25/17
04/25
06:09
04/25/17
06:09
Hot Stocks
Capricor announces 'positive' six-month results from Phase I/II HOPE trial »

Capricor Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RDWR

Radware

$15.42

0.25 (1.65%)

06:09
04/25/17
04/25
06:09
04/25/17
06:09
Hot Stocks
Radware approves new $40M repurchase plan »

Radware announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

DFRG

Del Frisco's

06:08
04/25/17
04/25
06:08
04/25/17
06:08
Hot Stocks
Del Frisco's to open two restaurants in FY17, four to seven in FY18 »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    May

RDWR

Radware

$15.42

0.25 (1.65%)

06:08
04/25/17
04/25
06:08
04/25/17
06:08
Earnings
Radware reports Q1 non-GAAP EPS 2c, consensus 1c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.